During the past decade, Volga District Medical Center Federal Medical and Biological Agency ( Site 0857) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)" #1 collaborator was "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator and "Seagen Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)" are "Urinary Bladder Cancer, Muscle-invasive" (2 trials). Many other conditions were trialed in "Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)" in a lesser frequency.

Most popular intervention types in "Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)" are "Drug" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (2 trials), "Surgery (radical cystectomy (RC) plus Pelvic Lymph Node Dissection [PLND])" (2 trials), "Cisplatin" (1 trials), "Enfortumab Vedotin" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Volga District Medical Center Federal Medical and Biological Agency ( Site 0857), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Volga District Medical Center Federal Medical and Biological Agency ( Site 0857), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".